Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism
2007-004953-27Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of apixaban in deep vein thrombosis (DVT), pulmonary embolism (PE) and venous thromboembolism (VTE) (3 arms), sponsored by Bristol Myers Squibb. Started Jun 2008; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2007-004953-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004953-27.